NEW YORK, Jan 24 (Reuters) - Mylan Inc said it received final U.S. approval to sell a generic version of Pfizer Inc's big-selling Protonix DR for preventing acid reflux, and will begin shipping the ...

Indian pharmaceutical company Dr Reddy's Laboratories Ltd on Thursday said it has launched a generic version of Protonix, a drug used to control the amount of acid in the stomach, in the United States ...

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE:RDY) today announced that it has launched Pantoprazole Sodium Delayed-Released tablets (20mg and 40mg strengths), a bioequivalent ...

PITTSBURGH, Jan. 24, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug ...

Sun Pharmaceutical Industries Ltd. announced today that it has commercially launched generic pantoprazole sodium delayed release (DR) tablets, 40mg, which is AB-rated to Wyeth's Protonix DR Tablets.

Jerusalem, April 23, 2010 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that a jury returned a verdict in the U.S. District Court for the District of New Jersey finding that ...

CINCINNATI, Jan. 30 Prasco announced today that, pursuantto an agreement it entered into with the ESI Lederle Division of Wyeth("ESI"), it is shipping the generic version of PROTONIX(R) ...

TORONTO, Oct. 18, 2010 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) today announced that the Food and Drug Administration (FDA) has accepted for filing its ...

Notably, pantoprazole belongs to a class of medicines that reduce stomach acid. “When taken for weeks or months without a ...

JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that a jury returned a verdict in the U.S. District Court for the District of New Jersey finding that ...